Skip to main content
. 2022 Jun 6;10(6):1331. doi: 10.3390/biomedicines10061331

Table 3.

Characteristics of the study population.

PC CCC
RFA Controls RFA Controls
N 11 8 8 13
Mean age (SD) 73.6 (9.9) 69.0 (6.2) 63.3 (7.3) 67.1 (9.0)
Males/females 7/4 4/4 5/3 9/4
Bismuth classification NA NA
Type I 1 1
Type II 1 4
Type III 4 4
Type IV 1 3
TNM stage
Stage I 3 0 0 1
Stage II 4 2 1 1
Stage III 2 2 3 7
Stage IV 2 4 4 4
Prior chemotherapy 1 2 2 3